SCHEMBL10112722

SCHEMBL10112722

C#CCOC(=O)Nc1ccc(N2CCC3(CC2)CCN([C@H]2CC[C@@H](O)CC2)C3=O)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 2/20 0.39
DGAT1 O75907 4/20 0.37
TRPV1 Q8NER1 2/20 0.37
DCTPP1 Q9H773 1/20 0.36
PDE7A Q13946 2/20 0.36
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
KCNQ3 O43525 1/20 0.35
KCNQ2 O43526 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
ACAT1 P24752 2/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10112720 0.89 DGAT1 (0.43) CRBNDGAT1TRPV1PDE7AMAPT
SCHEMBL10112739 0.88 SMN1; SMN2 (0.41) CRBNDGAT1TRPV1PDE7AKDM4E
SCHEMBL10112705 0.87 CRBN (0.45) CRBNTRPV1PDE7AKDM4EMAPT
SCHEMBL4720617 0.84 CRBN (0.45) CRBNTRPV1PDE7AKDM4EMAPT
SCHEMBL4826982 0.84 CRBN (0.45) CRBNTRPV1PDE7AKDM4EMAPT
SCHEMBL10112699 0.83 ROCK2 (0.35) DCTPP1ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL10112717 0.83 MALT1 (0.39) ALDH1A1CYP1A2CYP2D6CYP2C9PKM
SCHEMBL4570143 0.82 CRBN (0.45) CRBNDGAT1TRPV1PDE7AMAPT
SCHEMBL17082009 0.82 CRBN (0.45) CRBNDGAT1TRPV1PDE7AMAPT
SCHEMBL4570034 0.81 SMN1; SMN2 (0.39) CRBNMAPTALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193207-B2 Lactam compounds and methods of using the same INCYTE CORPORATION (US) 2012-06-05 US disclosed
US-8193207-B2 Lactam compounds and methods of using the same INCYTE CORPORATION (US) 2012-06-05 US disclosed
WO-2007067504-A2 LACTAM COMPOUNDS AND METHODS OF USING THE SAME INCYTE CORPORATION (US) 2007-06-14 WO disclosed
US-20070129345-A1 Lactam compounds and methods of using the same INCYTE CORPORATION 2007-06-07 US disclosed
US-20070129345-A1 Lactam compounds and methods of using the same INCYTE CORPORATION 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129345-A1 Lactam compounds and methods of using the same HSD11B1, HSD17B11, HSD17B1 CRBN 2523/4885DGAT1 802/4885TRPV1 4867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.